CHRS vs AMGN: Which Stock is Better?
Side-by-side comparison of Coherus Oncology Inc and Amgen Inc in 2026
CHRS
Coherus Oncology Inc
$1.99
AMGN
Amgen Inc
$350.16
Key Metrics Comparison
| Metric | CHRS | AMGN | Winner |
|---|---|---|---|
| Market Cap | $296.78M | $191.53B | AMGN |
| P/E Ratio | N/A | 24.93 | AMGN |
| EPS (TTM) | $N/A | $14.25 | AMGN |
| Revenue Growth | 0.6% | 0.1% | CHRS |
| Gross Margin | 67.2% | 70.8% | AMGN |
Analyze CHRS
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHRS or AMGN a better investment?
Comparing CHRS and AMGN: Coherus Oncology Inc has a market cap of $296.78M while Amgen Inc has $191.53B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHRS and AMGN?
CHRS (Coherus Oncology Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHRS or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CHRS or AMGN?
CHRS has higher revenue growth at 0.6% vs 0.1% for AMGN.
Which company is more profitable: CHRS or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 67.2% for CHRS.
Which is the larger company: CHRS or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $191.53B compared to $296.78M for CHRS.
Should I buy CHRS or AMGN in 2026?
Both CHRS and AMGN have investment merit. CHRS trades at $1.99 while AMGN trades at $350.16. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHRS and AMGN stock?
Key differences: Market Cap ($296.78M vs $191.53B), P/E Ratio (N/A vs 24.9x), Revenue Growth (0.6% vs 0.1%), Gross Margin (67.2% vs 70.8%).